SCHEMBL9609214

SCHEMBL9609214

COC(=O)c1cccc(C(=O)NC(=O)c2cc(OC)ccc2O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.53
RAB9A P51151 6/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
TP53 P04637 4/20 0.53
ALDH1A1 P00352 3/20 0.53
HPGD P15428 3/20 0.53
KDM4E B2RXH2 3/20 0.53
MAPT P10636 2/20 0.53
ALOX12 P18054 2/20 0.53
HSD17B10 Q99714 2/20 0.53
LMNA P02545 2/20 0.53
FADS1 O60427 1/20 0.52
MAPK1 P28482 2/20 0.50
PKM P14618 1/20 0.50
PLAU P00749 3/20 0.48
PLAT P00750 2/20 0.48
F2 P00734 1/20 0.48
F10 P00742 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9609319 0.88 CA1 (0.56) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL12829249 0.83 TSHR (0.56) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL9609272 0.81 RAB9A (0.53) NPC1RAB9AALDH1A1MAPTP2RX1
SCHEMBL5309470 0.80 RAB9A (0.60) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL9609315 0.77 APP (0.61) NPC1RAB9AMEN1KMT2ATP53
SCHEMBL17414607 0.77 P2RX1 (0.57) NPC1RAB9ASMN1; SMN2MEN1KMT2A
Methyl 2-Hydroxy-5-Methoxybenzoate SCHEMBL643758 0.76 CA1 (0.72) NPC1RAB9ASMN1; SMN2MEN1KMT2A
Methyl 2-Hydroxy-5-Methoxybenzoate SCHEMBL29709382 0.76 CA1 (0.72) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL12228490 0.75 HPGD (0.68) NPC1RAB9ASMN1; SMN2MEN1KMT2A
Methyl 3-Methoxybenzoate SCHEMBL384913 0.75 SMN1; SMN2 (0.73) NPC1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8957140-B2 Triazine derivative, ultraviolet absorber, and resin composition FUJIFILM CORPORATION (JP) 2015-02-17 US disclosed
US-20120136098-A1 NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION FUJIFILM CORPORATION (JP) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136098-A1 NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION C1R, RPSA, H1-2 NPC1 4182/4885RAB9A 2727/4885SMN1; SMN2 3721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.